基于下腹部手术后静脉血栓栓塞原始危险分级的药物预防的临床意义。

Q4 Medicine
Manabu Shimomura, Masatoshi Kochi, Takao Hinoi, Hiroyuki Egi, Tomohiro Adachi, Tsuyoshi Kobayashi, Hirotaka Tashiro, Hideki Ohdan
{"title":"基于下腹部手术后静脉血栓栓塞原始危险分级的药物预防的临床意义。","authors":"Manabu Shimomura,&nbsp;Masatoshi Kochi,&nbsp;Takao Hinoi,&nbsp;Hiroyuki Egi,&nbsp;Tomohiro Adachi,&nbsp;Tsuyoshi Kobayashi,&nbsp;Hirotaka Tashiro,&nbsp;Hideki Ohdan","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Pharmacological prophylaxis was not routinely administrated following gastroenterological surgery because of concerns about bleeding complications. We tried to establish the original risk classification to determine the indication for pharmacological prophylaxis for selected patients at high risk of venous thromboembolism (VTE). One hundred and fifty-six consecutive patients who underwent lower abdominal elective surgery were divided into three groups (highest, high, and low risk groups) based on the original risk classification. Pharmacological prophylaxis was indicated for patients in the highest and high risk groups. We investigated safety and efficacy of the pharmacological prophylaxis based on this classification. Sixteen patients were classified in the highest, 50 in the high, and 90 in the low risk groups. Pharmacological prophylaxis was used for 59 cases (37.8%). There was no symptomatic pulmonary embolism or major bleeding complications. There were no significant differences in the occurrence of postoperative complications, analgesia use, and median postoperative pain scores for the three groups. In the highest and high risk groups administrated pharmacological prophylaxis, fibrin degradation products (FDP) and D-dimer did not change between postoperative day 1 and day 7. These data suggested the clinical significance of the pharmacological prophylaxis based on the original risk classification.</p>","PeriodicalId":12860,"journal":{"name":"Hiroshima journal of medical sciences","volume":"65 3-4","pages":"53-59"},"PeriodicalIF":0.0000,"publicationDate":"2016-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical Significance of Pharmacological Prophylaxis based on the Original Risk Classification of Venous Thromboembolism after Lower Abdominal Surgery.\",\"authors\":\"Manabu Shimomura,&nbsp;Masatoshi Kochi,&nbsp;Takao Hinoi,&nbsp;Hiroyuki Egi,&nbsp;Tomohiro Adachi,&nbsp;Tsuyoshi Kobayashi,&nbsp;Hirotaka Tashiro,&nbsp;Hideki Ohdan\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Pharmacological prophylaxis was not routinely administrated following gastroenterological surgery because of concerns about bleeding complications. We tried to establish the original risk classification to determine the indication for pharmacological prophylaxis for selected patients at high risk of venous thromboembolism (VTE). One hundred and fifty-six consecutive patients who underwent lower abdominal elective surgery were divided into three groups (highest, high, and low risk groups) based on the original risk classification. Pharmacological prophylaxis was indicated for patients in the highest and high risk groups. We investigated safety and efficacy of the pharmacological prophylaxis based on this classification. Sixteen patients were classified in the highest, 50 in the high, and 90 in the low risk groups. Pharmacological prophylaxis was used for 59 cases (37.8%). There was no symptomatic pulmonary embolism or major bleeding complications. There were no significant differences in the occurrence of postoperative complications, analgesia use, and median postoperative pain scores for the three groups. In the highest and high risk groups administrated pharmacological prophylaxis, fibrin degradation products (FDP) and D-dimer did not change between postoperative day 1 and day 7. These data suggested the clinical significance of the pharmacological prophylaxis based on the original risk classification.</p>\",\"PeriodicalId\":12860,\"journal\":{\"name\":\"Hiroshima journal of medical sciences\",\"volume\":\"65 3-4\",\"pages\":\"53-59\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hiroshima journal of medical sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hiroshima journal of medical sciences","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

由于担心出血并发症,胃肠外科手术后不常规给予药物预防。我们试图建立最初的风险分类,以确定对静脉血栓栓塞(VTE)高危患者进行药物预防的指征。156例连续接受下腹部择期手术的患者根据最初的风险分类分为三组(最高、高、低风险组)。最高和高危组的患者应采取药物预防。我们在此基础上研究了药物预防的安全性和有效性。16例患者被分为高危组,50例为高危组,90例为低危组。药物预防59例(37.8%)。无症状性肺栓塞或大出血并发症。三组患者在术后并发症的发生、镇痛药的使用和中位术后疼痛评分方面均无显著差异。在给予药物预防的最高和高风险组中,纤维蛋白降解产物(FDP)和d -二聚体在术后第1天至第7天没有变化。这些数据提示在原有风险分类基础上进行药物预防的临床意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Clinical Significance of Pharmacological Prophylaxis based on the Original Risk Classification of Venous Thromboembolism after Lower Abdominal Surgery.

Pharmacological prophylaxis was not routinely administrated following gastroenterological surgery because of concerns about bleeding complications. We tried to establish the original risk classification to determine the indication for pharmacological prophylaxis for selected patients at high risk of venous thromboembolism (VTE). One hundred and fifty-six consecutive patients who underwent lower abdominal elective surgery were divided into three groups (highest, high, and low risk groups) based on the original risk classification. Pharmacological prophylaxis was indicated for patients in the highest and high risk groups. We investigated safety and efficacy of the pharmacological prophylaxis based on this classification. Sixteen patients were classified in the highest, 50 in the high, and 90 in the low risk groups. Pharmacological prophylaxis was used for 59 cases (37.8%). There was no symptomatic pulmonary embolism or major bleeding complications. There were no significant differences in the occurrence of postoperative complications, analgesia use, and median postoperative pain scores for the three groups. In the highest and high risk groups administrated pharmacological prophylaxis, fibrin degradation products (FDP) and D-dimer did not change between postoperative day 1 and day 7. These data suggested the clinical significance of the pharmacological prophylaxis based on the original risk classification.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Hiroshima journal of medical sciences
Hiroshima journal of medical sciences Medicine-Medicine (all)
CiteScore
0.30
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信